跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NYZOL 300 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NYZOL 300 MG COMPRIMIDOS
Approved
STANDARD
NYZOL 300 MG COMPRIMIDOS
Neuraxpharm Spain S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 20, 2022
Approval ID
4493bc5ffd2e7688
Company
Neuraxpharm Spain S.L.
Type
Standard
Approval Details
Approval Id
4493bc5ffd2e7688
Drug Cima Aemps Name
NYZOL 300 MG COMPRIMIDOS
Register Number
87869
Holder Company Name
Neuraxpharm Spain S.L.
Marketing Company Name
Neuraxpharm Spain S.L.
Authorization Date
2022-06-20
Dosage Form
COMPRIMIDO
Dose
300 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Neuraxpharm Spain S.L.
Active Ingredients
ZONISAMIDA
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 20, 2022
Approval ID
4493bc5ffd2e7688
Type
Standard
Back to CIMA-AEMPS Approvals